ATE367378T1 - Bis(2-aryl-5-pyridyl)derivate - Google Patents

Bis(2-aryl-5-pyridyl)derivate

Info

Publication number
ATE367378T1
ATE367378T1 AT02738821T AT02738821T ATE367378T1 AT E367378 T1 ATE367378 T1 AT E367378T1 AT 02738821 T AT02738821 T AT 02738821T AT 02738821 T AT02738821 T AT 02738821T AT E367378 T1 ATE367378 T1 AT E367378T1
Authority
AT
Austria
Prior art keywords
sup
group
formula
integer
pyridyl
Prior art date
Application number
AT02738821T
Other languages
English (en)
Inventor
Hiroyuki Ishiwata
Seiichi Sato
Mototsugu Kabeya
Soichi Oda
Makoto Suda
Manabu Shibasaki
Original Assignee
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co filed Critical Kowa Co
Application granted granted Critical
Publication of ATE367378T1 publication Critical patent/ATE367378T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT02738821T 2001-06-29 2002-06-27 Bis(2-aryl-5-pyridyl)derivate ATE367378T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/893,680 US6890940B2 (en) 2001-06-29 2001-06-29 Bis(2-aryl-5-pyridyl) derivatives

Publications (1)

Publication Number Publication Date
ATE367378T1 true ATE367378T1 (de) 2007-08-15

Family

ID=25401909

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02738821T ATE367378T1 (de) 2001-06-29 2002-06-27 Bis(2-aryl-5-pyridyl)derivate

Country Status (6)

Country Link
US (1) US6890940B2 (de)
EP (1) EP1403251B1 (de)
JP (1) JP4231405B2 (de)
AT (1) ATE367378T1 (de)
DE (1) DE60221251T2 (de)
WO (1) WO2003002538A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6395753B1 (en) * 2001-08-30 2002-05-28 Kowa Co., Ltd. Cyclic amine compounds and pharmaceutical composition containing the same
WO2007084611A2 (en) * 2006-01-20 2007-07-26 Landmark Graphics Corporation Dynamic production system management
JO3598B1 (ar) 2006-10-10 2020-07-05 Infinity Discovery Inc الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
BR112012019120A2 (pt) 2010-02-03 2016-06-28 Infinity Pharmaceuticais Inc forma sólida, composição farmacêutica, método de preparação do composto 1, método de tratamento de uma condição mediada por faah
KR102695210B1 (ko) 2018-06-05 2024-08-13 크리네틱스 파마슈티칼스, 인크. 멜라노코르틴 아형-2 수용체(mc2r) 길항제 및 이의 용도
WO2021091788A1 (en) * 2019-11-07 2021-05-14 Crinetics Pharmaceuticals, Inc. Melanocortin subtype-2 receptor (mc2r) antagonists and uses thereof
BR112023018816A2 (pt) 2021-03-19 2023-10-31 Crinetics Pharmaceuticals Inc Antagonista do receptor de melanocortina subtipo-2 (mc2r) para o tratamento de doença
CN113292514B (zh) * 2021-04-07 2022-11-15 浙江华显光电科技有限公司 一种哌嗪衍生物及包含其的有机光电器件

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59167564A (ja) 1983-03-11 1984-09-21 Taiho Yakuhin Kogyo Kk スルホニウム化合物
JPH01106818A (ja) 1987-10-20 1989-04-24 Teijin Ltd 抗アレルギー剤
JP2991897B2 (ja) 1993-06-30 1999-12-20 ハウス食品株式会社 ガゼットタイプの食品充填用包装袋
JPH08109177A (ja) 1994-08-18 1996-04-30 Asahi Chem Ind Co Ltd シクロアルキルアルキルアミン誘導体およびその用途
JP3265134B2 (ja) 1994-09-20 2002-03-11 帝人株式会社 含窒素二環性複素環誘導体およびこれを含有する医薬製剤
PT787491E (pt) 1994-10-17 2000-11-30 Aventis Pharma Ltd Composicao para a profilaxia e para o tratamento de doencas alergicas de tipo i
RU2200730C2 (ru) 1996-07-31 2003-03-20 Шионоги Энд Ко., Лтд. Пара-терфенильные соединения, способ их получения (варианты) и фармацевтическая композиция (варианты)
US6340682B1 (en) 1996-08-23 2002-01-22 Kowa Co., Ltd. Diamide compound and drugs containing the same
JP4382880B2 (ja) 1996-10-11 2009-12-16 興和株式会社 新規なジアミド化合物及びこれを含有する医薬
GB9622363D0 (en) * 1996-10-28 1997-01-08 Celltech Therapeutics Ltd Chemical compounds
JPH10324631A (ja) 1997-05-22 1998-12-08 Fujisawa Pharmaceut Co Ltd IgE抗体産生抑制剤
CA2304713C (en) 1997-10-14 2003-06-10 Asahi Kasei Kogyo Kabushiki Kaisha Biphenyl-5-alkanoic acid derivatives and use thereof
AU2516199A (en) 1998-01-12 1999-07-26 Novartis Ag Pyridinylpyrimidine amines as immunoglobuline e (ige) synthesis inhibitors
PL341984A1 (en) 1998-01-28 2001-05-07 Shionogi & Co Novel tricycle compounds
DE69937045T2 (de) 1998-02-19 2008-05-29 Kowa Co., Ltd., Nagoya Cyclische amidderivate
JPH11269192A (ja) 1998-03-24 1999-10-05 The Nikka Wisky Distilling Co Ltd フラボン配糖体
KR100682276B1 (ko) 1998-07-24 2007-02-28 데이진 가부시키가이샤 안트라닐산 유도체

Also Published As

Publication number Publication date
US6890940B2 (en) 2005-05-10
EP1403251A1 (de) 2004-03-31
JPWO2003002538A1 (ja) 2004-10-14
EP1403251B1 (de) 2007-07-18
EP1403251A4 (de) 2005-04-13
JP4231405B2 (ja) 2009-02-25
WO2003002538A1 (fr) 2003-01-09
DE60221251D1 (de) 2007-08-30
US20030022886A1 (en) 2003-01-30
DE60221251T2 (de) 2008-04-10

Similar Documents

Publication Publication Date Title
ATE345122T1 (de) Stabile emulsionszubereitungen
ATE408597T1 (de) Aliphatische stickstoffhaltige fünfgliedrige ringverbindungen
DE69129611D1 (de) Sulfonamid-Derivate
ATE360011T1 (de) Aminoalkoholderivate
TR199901933T1 (xx) 3-Piperidil-4-oksokuinazolin t�revleri ve bunlar� i�eren farmas�tik terkipler.
EA200100310A1 (ru) Кислородсодержащие гетероциклические соединения
EP1400513A4 (de) Unsymmetrische cyclische diaminverbindung
DE60221251D1 (de) Bis(2-aryl-5-pyridyl)derivate
ATE372320T1 (de) Cyclische amidderivate
ATE37183T1 (de) Chinazolin- und isochinolin-derivate.
TR200003652T2 (tr) Glisin antagonistleri olarak tetrahidrokuinolin türevleri.
DK1826214T3 (da) Sammensætning omfattende ferrocen-derivater og brændstofsammensætning omfattende sådanne derivater
DK0601191T3 (da) Hidtil ukendt tetracyklisk forbindelse
DE60221250D1 (de) Bis(5-aryl-2-pyridyl)derivate
ATE223381T1 (de) Bis(acridinecarboxamide) und bis(phenazinecarboxamide) als antikrebsmittel
EA200200665A1 (ru) Новые соединения бензолсульфонамида, способ их получения и фармацевтические композиции, их содержащие
MEP12408A (en) Acyloxypyrrolidine derivatives and use thereof as ligands of v1b or both v1b and v1a receptors
DE60222281D1 (de) Zusammensetzung
NO20005328L (no) Fosfonsyrediesterderivater
DE69526332D1 (de) Indol-derivate
ATE318265T1 (de) Amidin-derivate, ihre herstellung und verwendung als medikamenten
DK1023287T3 (da) Derivater af 3-oxo-(2H)-1,2,4-triazin som ligander for 5HT1a-receptorer
RU94016363A (ru) Производные 2-аминопиразин 5-карбоксамида, их получение и применение в терапии

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties